CANY
MORF

Caxton Associates (New York)’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Caxton Associates (New York)’s Portfolio MORF Stock Details MORF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,626
Closed -$265K – 628
2021
Q2 		$265K Sell
4,626
-1,016
-18% -$55.9K 0.03% 346
2021
Q1 		$357K Buy
+5,642
New +$259K 0.03% 234

Other funds holding MORF

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Caxton Associates (New York)'s MORF Position: Q3 2021 in Review

Caxton Associates (New York) sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2021, closing a stake of 4,626 shares — an estimated $265K sold.

Caxton Associates (New York) first reported a position in MORF in Q1 2021 and held it in 2 quarters. The position peaked at $357K in Q1 2021. 110 funds tracked by Wall St. Rank hold MORF as of Q3 2021.

  • Caxton Associates (New York) reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Caxton Associates (New York) sold 4,626 Morphic Holding, Inc. Common Stock shares in Q3 2021, an estimated $265K.
  • Caxton Associates (New York) first reported a position in Morphic Holding, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Caxton Associates (New York)'s Morphic Holding, Inc. Common Stock position peaked at $357K in Q1 2021.
  • 110 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2021.

Based on Caxton Associates (New York)'s 13F filing for Q3 2021, filed 15 Nov 2021.